Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Gilead Sciences
GILD Rank #59 Health Care
$149.58 +0.42%

Key Statistics

Market Cap
$185.69B
Volume (24h)
$1.1B
P/E Ratio
22.1
EPS
$6.77
1 Day
+0.42%
7 Day
-1.20%
YTD
-2.40%
Sector
Health Care
S&P 500 Rank
#59
52W Low: $134.02 52W High: $171.12

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops, manufactures, and commercializes therapies for the treatment of life-threatening infectious diseases, including HIV/AIDS, liver diseases, and cancer. The company's key products include Sovaldi, Harvoni, Epclusa, and Biktarvy, which are used to treat various viral infections and cancers. As a leader in the development of antiviral therapies, Gilead Sciences plays a significant role in improving patient outcomes and addressing some of the world's most pressing public health challenges.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,027.59 -2.32% JNJ — Johnson & Johnson $247.67 -0.31% ABBV — AbbVie $233.22 +0.49% MRK — Merck & Co. $121.20 -2.11% UNH — UnitedHealth Group $290.56 -0.92% AMGN — Amgen $384.71 -0.89% ABT — Abbott Laboratories $114.46 -1.62% TMO — Thermo Fisher Scientific $506.43 -2.82% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.